This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AlloSource Donates Tissue To Innovative Research To Continue Honoring Mission

The gift of donation lives on by advancing the science of medicine

CENTENNIAL, Colo., Jan. 29, 2013 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, today announced the donation of research tissue to the Steadman Philippon Research Institute (SPRI) in order to further honor the gift of tissue donation.

"The importance of donated research tissue often gets lost," said Dr. Ross Wilkins, Medical Director at AlloSource. "Even if the tissue cannot be used for transplantation, what we can learn from research tissue is every bit as likely to save and enhance lives."

Donated tissue, though mostly used for allograft procedures, is at times ineligible for transplantation.  In order to ensure the donor's wishes are met, AlloSource collaborates with academic Universities and Institutes that perform clinically applicable research.  This is always accompanied by a strict internal review process on the overall benefit of the proposed research.  These donated gifts were used by SPRI to research different surgical practices in hopes of better outcomes and faster recovery periods for future patients.   

"We hope to decide which reconstructive technique is superior of the two currently used in clinical practice," said Dr. Coen Wijdicks, Director of the Biomedical Engineering Department and Senior Staff Scientist at SPRI.  "That way we can improve both subjective and objective patient outcomes after reconstructive surgery."

Located in Vail, Colo., SPRI is a nonprofit organization employing scientists and researchers.  They are recognized globally for their research in osteoarthritis, surgical techniques and injury prevention and rehabilitation.  Over nine respected doctors and scientists participated in the study using AlloSource-provided tissue, including, the Chief Medical Officer, Dr. Robert LaPrade

"The use of this donated tissue, which is the same tissue that we would otherwise use in surgical cases, provides an invaluable means to improve patient care for this difficult clinical problem," said Dr. LaPrade.  "We are extremely grateful to the donor families for allowing us the opportunity to improve patient care and outcomes."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs